Advertisement

Current Neurology and Neuroscience Reports

, Volume 12, Issue 3, pp 325–333 | Cite as

What We Know about the Generation of Nystagmus and Other Ocular Oscillations: Are We Closer to Identifying Therapeutic Targets?

  • Rebecca Jane McLeanEmail author
  • Irene Gottlob
  • Frank Antony Proudlock
Neuro-Ophthalmology (G Plant, Section Editor)

Abstract

Mechanisms underlying acquired nystagmus are better understood than those leading to infantile nystagmus. Accordingly, further progress has been made in the development of effective therapies for acquired nystagmus, mainly through pharmacological interventions. Some of these therapies have been developed under the guidance of findings from experimental animal models. Although mechanisms behind infantile nystagmus are less understood, progress has been made in determining the genetic basis of nystagmus and characterizing associated sensory deficits. Pharmacological, surgical, and other treatments options for infantile nystagmus are now emerging. Further investigations are required for all forms of nystagmus to produce high-quality evidence, such as randomized controlled trials, upon which clinicians can make appropriate treatment decisions.

Keywords

Nystagmus Acquired Infantile Treatment Mechanisms Pharmacological Ocular oscillations 

Notes

Disclosure

Conflicts of interest: R.J. McLean: has received grant support from the Ulverscroft Foundation; I. Gottlob: has received grant support from the Ulverscroft Foundation; F.A. Proudlock: has received grant support from the Ulverscroft Foundation.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Leigh RJ, Zee DS. The neurology of eye movements. 4th ed. ed. Oxford: Oxford University Press; 2006. x, 763 p. p.Google Scholar
  2. 2.
    Summers CG. Albinism: classification, clinical characteristics, and recent findings. Optom Vis Sci. 2009;86(6):659–62. Epub 2009/04/25.PubMedCrossRefGoogle Scholar
  3. 3.
    Leigh RJ, Das VE, Seidman SH. A neurobiological approach to acquired nystagmus. Ann N Y Acad Sci. 2002;956:380–90.PubMedCrossRefGoogle Scholar
  4. 4.
    Stone LS, Lisberger SG. Visual responses of Purkinje cells in the cerebellar flocculus during smooth-pursuit eye movements in monkeys. II. Complex spikes. J Neurophysiol. 1990;63(5):1262–75.PubMedGoogle Scholar
  5. 5.
    Zee DS, Yamazaki A, Butler PH, Gucer G. Effects of ablation of flocculus and paraflocculus of eye movements in primate. J Neurophysiol. 1981;46(4):878–99.PubMedGoogle Scholar
  6. 6.
    Waespe W, Cohen B, Raphan T. Dynamic modification of the vestibulo-ocular reflex by the nodulus and uvula. Science. 1985;228(4696):199–202.PubMedCrossRefGoogle Scholar
  7. 7.
    Arnold DB, Robinson DA, Leigh RJ. Nystagmus induced by pharmacological inactivation of the brainstem ocular motor integrator in monkey. Vis Res. 1999;39(25):4286–95.PubMedCrossRefGoogle Scholar
  8. 8.
    Abadi RV. Mechanisms underlying nystagmus. J Roy Soc Med. 2002;95(5):231–4. Epub 2002/05/02.PubMedCrossRefGoogle Scholar
  9. 9.
    Harris C, Berry D. A developmental model of infantile nystagmus. Semin Ophthalmol. 2006;21(2):63–9. Epub 2006/05/17.PubMedCrossRefGoogle Scholar
  10. 10.
    McLean RJ, Gottlob I. The pharmacological treatment of nystagmus: a review. Expert Opin Pharmacother. 2009;10(11):1805–16. Epub 2009/07/16.PubMedCrossRefGoogle Scholar
  11. 11.
    • McLean RJ, Gottlob I. A review of nystagmus and current pharmacological treatments. CML- Ophthlamology. 2010;20(4):125–36. A current review article, useful for clinicians, when considering pharmacological treatment for nystagmus. Google Scholar
  12. 12.
    •• McLean R, Proudlock F, Thomas S, Degg C, Gottlob I. Congenital nystagmus: randomized, controlled, double-masked trial of memantine/gabapentin.[see comment]. Ann Neurol. 2007;61(2):130–8. The first randomized controlled trial demonstrating the positive effect of gabapentin and memantine for IN. PubMedCrossRefGoogle Scholar
  13. 13.
    Shery T, Proudlock FA, Sarvananthan N, McLean RJ, Gottlob I. The effects of gabapentin and memantine in acquired and congenital nystagmus: a retrospective study. Br J Ophthalmol. 2006;90(7):839–43.PubMedCrossRefGoogle Scholar
  14. 14.
    Nelson LB, Ervin-Mulvey LD, Calhoun JH, Harley RD, Keisler MS. Surgical management for abnormal head position in nystagmus: the augmented modified Kestenbaum procedure. Br J Ophthalmol. 1984;68(11):796–800.PubMedCrossRefGoogle Scholar
  15. 15.
    Campos EC, Schiavi C, Bellusci C. Surgical management of anomalous head posture because of horizontal gaze palsy or acquired vertical nystagmus.[see comment]. Eye. 2003;17(5):587–92.PubMedCrossRefGoogle Scholar
  16. 16.
    Hertle RW, Dell'Osso LF, FitzGibbon EJ, Yang D, Mellow SD. Horizontal rectus muscle tenotomy in children with infantile nystagmus syndrome: a pilot study. J Aapos Am Assoc Pediatr Ophthalmol Strabismus. 2004;8(6):539–48.CrossRefGoogle Scholar
  17. 17.
    Hingorani M, Williamson KA, Moore AT, van Heyningen V. Detailed ophthalmologic evaluation of 43 individuals with PAX6 mutations. Investig Ophthalmol Vis Sci. 2009;50(6):2581–90. Epub 2009/02/17.CrossRefGoogle Scholar
  18. 18.
    Kohl S, Jagle H, Sharpe LT, Wissinger B. Achromatopsia. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews. 17 Feb, 2004 ed. Seattle: University of Washington; 2004.Google Scholar
  19. 19.
    Tarpey P, Thomas S, Sarvananthan N, Mallya U, Lisgo S, Talbot CJ, et al. Mutations in FRMD7, a newly identified member of the FERM family, cause X-linked idiopathic congenital nystagmus. Nat Genet. 2006;38(11):1242–4.PubMedCrossRefGoogle Scholar
  20. 20.
    Mohammad S, Gottlob I, Kumar A, Thomas M, Degg C, Sheth V, et al. The functional significance of foveal abnormalities in albinism measured using spectral-domain optical coherence tomography. Ophthalmology. 2011;118(8):1645–52. Epub 2011/05/17.PubMedCrossRefGoogle Scholar
  21. 21.
    Proudlock F, Gottlob I. Foveal development and nystagmus. Ann N Y Acad Sci. 2011;1233(1):292–7. Epub 2011/09/29.PubMedCrossRefGoogle Scholar
  22. 22.
    Thomas MG, Kumar A, Mohammad S, Proudlock FA, Engle EC, Andrews C, et al. Structural grading of foveal hypoplasia using spectral-domain optical coherence tomography a predictor of visual acuity? Ophthalmology. 2011;118(8):1653–60. Epub 2011/05/03.PubMedCrossRefGoogle Scholar
  23. 23.
    Thomas MG, Kumar A, Thompson JR, Proudlock FA, Straatman K, Gottlob I. Is high-resolution spectral domain optical coherence tomography reliable in nystagmus? Br J Ophthalmol. 2011. Epub 2011/09/29.Google Scholar
  24. 24.
    Wagner JN, Glaser M, Brandt T, Strupp M. Downbeat nystagmus: aetiology and comorbidity in 117 patients. J Neurol Neurosurg Psychiatry. 2008;79(6):672–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Bense S, Best C, Buchholz HG, Wiener V, Schreckenberger M, Bartenstein P, et al. 18F-fluorodeoxyglucose hypometabolism in cerebellar tonsil and flocculus in downbeat nystagmus. Neuroreport. 2006;17(6):599–603.PubMedCrossRefGoogle Scholar
  26. 26.
    Kalla R, Deutschlander A, Hufner K, Stephan T, Jahn K, Glasauer S, et al. Detection of floccular hypometabolism in downbeat nystagmus by fMRI. Neurology. 2006;66(2):281–3.PubMedCrossRefGoogle Scholar
  27. 27.
    Marti S, Straumann D, Buttner U, Glasauer S. A model-based theory on the origin of downbeat nystagmus. Exp Brain Res. 2008;188(4):613–31.PubMedCrossRefGoogle Scholar
  28. 28.
    Lee AG, Brazis PW. Localizing forms of nystagmus: symptoms, diagnosis, and treatment. Curr Neurol Neurosci Rep. 2006;6(5):414–20.PubMedCrossRefGoogle Scholar
  29. 29.
    Averbuch-Heller L, Leigh RJ. Medical treatments for abnormal eye movements: pharmacological, optical and immunological strategies. Aust N Z J Ophthalmol. 1997;25(1):7–13.PubMedGoogle Scholar
  30. 30.
    Barton JJ, Cox TA. Acquired pendular nystagmus in multiple sclerosis: clinical observations and the role of optic neuropathy. J Neurol Neurosurg Psychiatry. 1993;56(3):262–7. Epub 1993/03/01.PubMedCrossRefGoogle Scholar
  31. 31.
    • Tilikete C, Jasse L, Pelisson D, Vukusic S, Durand-Dubief F, Urquizar C, et al. Acquired pendular nystagmus in multiple sclerosis and oculopalatal tremor. Neurology. 2011;76(19):1650–7. Epub 2011/05/11. A study that emphasizes the need to consider APN that is associated with MS and APN in oculopalatal tremor as two different clinical entities based upon the clinical characteristics.PubMedCrossRefGoogle Scholar
  32. 32.
    Das VE, Oruganti P, Kramer PD, Leigh RJ. Experimental tests of a neural-network model for ocular oscillations caused by disease of central myelin. Exp Brain Res. 2000;133(2):189–97.PubMedCrossRefGoogle Scholar
  33. 33.
    Lopez LI, Bronstein AM, Gresty MA, Du Boulay EP, Rudge P. Clinical and MRI correlates in 27 patients with acquired pendular nystagmus. Brain. 1996;119(Pt 2):465–72.PubMedCrossRefGoogle Scholar
  34. 34.
    Ruigrok TJ, de Zeeuw CI, Voogd J. Hypertrophy of inferior olivary neurons: a degenerative, regenerative or plasticity phenomenon. Eur J Morphol. 1990;28(2–4):224–39.PubMedGoogle Scholar
  35. 35.
    Leigh RJ, Robinson DA, Zee DS. A hypothetical explanation for periodic alternating nystagmus: instability in the optokinetic-vestibular system. Ann N Y Acad Sci. 1981;374:619–35.PubMedCrossRefGoogle Scholar
  36. 36.
    • Proudlock FA, Gottlob I. Nystagmus in childhood. In: Taylor D, Hoyt CS, editors. Pediatric ophthalmology and strabismus. 4th ed. ed. Edinburgh; New York: Elsevier; 2012. A comprehensive book chapter, very useful for clinicians, for identifying and characterizing IN. Google Scholar
  37. 37.
    Betts-Henderson J, Bartesaghi S, Crosier M, Lindsay S, Chen HL, Salomoni P, et al. The nystagmus-associated FRMD7 gene regulates neuronal outgrowth and development. Hum Mol Genet. 2010;19(2):342–51. Epub 2009/11/07.PubMedCrossRefGoogle Scholar
  38. 38.
    Abadi RV, Bjerre A. Motor and sensory characteristics of infantile nystagmus. Br J Ophthalmol. 2002;86(10):1152–60.PubMedCrossRefGoogle Scholar
  39. 39.
    Thomas S, Proudlock FA, Sarvananthan N, Roberts EO, Awan M, McLean R, et al. Phenotypical characteristics of idiopathic infantile nystagmus with and without mutations in FRMD7. Brain. 2008;131(Pt 5):1259–67. Epub 2008/03/29.PubMedGoogle Scholar
  40. 40.
    Dell'Osso LF, Daroff RB. Congenital nystagmus waveforms and foveation strategy. Doc Ophthalmol. 1975;39(1):155–82.PubMedCrossRefGoogle Scholar
  41. 41.
    Abadi RV, Worfolk R. Retinal slip velocities in congenital nystagmus. Vis Res. 1989;29(2):195–205.PubMedCrossRefGoogle Scholar
  42. 42.
    Goldstein HP, Gottlob I, Fendick MG. Visual remapping in infantile nystagmus. Vis Res. 1992;32(6):1115–24.PubMedCrossRefGoogle Scholar
  43. 43.
    Dell'Osso LF, Jacobs JB. An expanded nystagmus acuity function: intra- and intersubject prediction of best-corrected visual acuity. Doc Ophthalmol. 2002;104(3):249–76.PubMedCrossRefGoogle Scholar
  44. 44.
    Optican LM, Zee DS. A hypothetical explanation of congenital nystagmus. Biol Cybern. 1984;50(2):119–34. Epub 1984/01/01.PubMedCrossRefGoogle Scholar
  45. 45.
    Jacobs JB, Dell'Osso LF. Congenital nystagmus: hypotheses for its genesis and complex waveforms within a behavioral ocular motor system model. J Vis. 2004;4(7):604–25. Epub 2004/08/28.PubMedCrossRefGoogle Scholar
  46. 46.
    Akman OE, Broomhead DS, Clement RA, Abadi RV. Nonlinear time series analysis of jerk congenital nystagmus. J Comput Neurosci. 2006;21(2):153–70. Epub 2006/05/30.PubMedCrossRefGoogle Scholar
  47. 47.
    Akman OE, Broomhead DS, Abadi RV, Clement RA. Eye movement instabilities and nystagmus can be predicted by a nonlinear dynamics model of the saccadic system. J Math Biol. 2005;51(6):661–94. Epub 2005/06/09.PubMedCrossRefGoogle Scholar
  48. 48.
    Committee for the Classification of Eye Movement Abnormalities and Strabismus (CEMAS) Workshop. A classification of eye movement abnormalities and strabismus (CEMAS): report of a National Eye Institute sponsored workshop. http://www.nei.nih.gov/news/statements/cemas.pdf Accessed 24th May, 2011. 2007.
  49. 49.
    Strupp M, Schuler O, Krafczyk S, Jahn K, Schautzer F, Buttner U, et al. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.[see comment]. Neurology. 2003;61(2):165–70.PubMedGoogle Scholar
  50. 50.
    Tsunemi T, Ishikawa K, Tsukui K, Sumi T, Kitamura K, Mizusawa H. The effect of 3,4-diaminopyridine on the patients with hereditary pure cerebellar ataxia. J Neurol Sci. 2010;292(1–2):81–4. Epub 2010/02/26.PubMedCrossRefGoogle Scholar
  51. 51.
    Pierrot-Deseilligny C, Milea D. Vertical nystagmus: clinical facts and hypotheses. Brain. 2005;128(Pt 6):1237–46.PubMedCrossRefGoogle Scholar
  52. 52.
    Leigh RJ. Potassium channels, the cerebellum, and treatment for downbeat nystagmus.[comment]. Neurology. 2003;61(2):158–9.PubMedGoogle Scholar
  53. 53.
    Strupp M, Kalla R, Glasauer S, Wagner J, Hufner K, Jahn K, et al. Aminopyridines for the treatment of cerebellar and ocular motor disorders. Progr Brain Res. 2008;171:535–41.CrossRefGoogle Scholar
  54. 54.
    Kalla R, Glasauer S, Buttner U, Brandt T, Strupp M. 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus. Brain. 2007;130(Pt 9):2441–51.PubMedCrossRefGoogle Scholar
  55. 55.
    Alvina K, Khodakhah K. The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia. J Neurosci. 2010;30(21):7258–68. Epub 2010/05/28.PubMedCrossRefGoogle Scholar
  56. 56.
    Sander T, Sprenger A, Marti S, Naumann T, Straumann D, Helmchen C. Effect of 4-aminopyridine on gravity dependence and neural integrator function in patients with idiopathic downbeat nystagmus. J Neurol. 2011;258(4):618–22. Epub 2010/11/09.PubMedCrossRefGoogle Scholar
  57. 57.
    • Kalla R, Spiegel R, Claassen J, Bardins S, Hahn A, Schneider E, et al. Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus. J Neuro Ophthalmol Offic J N Am Neuro Ophthalmol Soc. 2011. Epub 2011/07/08. A clinical trial reporting that although 3,4-DAP and 4-AP both improve DBN, 4-AP produces a more pronounced decrease in DBN. Google Scholar
  58. 58.
    Glasauer S, Kalla R, Buttner U, Strupp M, Brandt T. 4-aminopyridine restores visual ocular motor function in upbeat nystagmus. J Neurol Neurosurg Psychiatry. 2005;76(3):451–3.PubMedCrossRefGoogle Scholar
  59. 59.
    Jabbari B, Rosenberg M, Scherokman B, Gunderson CH, McBurney JW, McClintock W. Effectiveness of trihexyphenidyl against pendular nystagmus and palatal myoclonus: evidence of cholinergic dysfunction. Mov Disord. 1987;2(2):93–8.PubMedCrossRefGoogle Scholar
  60. 60.
    Barton JJ, Huaman AG, Sharpe JA. Muscarinic antagonists in the treatment of acquired pendular and downbeat nystagmus: a double-blind, randomized trial of three intravenous drugs. Ann Neurol. 1994;35(3):319–25.PubMedCrossRefGoogle Scholar
  61. 61.
    Averbuch-Heller L, Tusa RJ, Fuhry L, Rottach KG, Ganser GL, Heide W, et al. A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus. Ann Neurol. 1997;41(6):818–25.PubMedCrossRefGoogle Scholar
  62. 62.
    Bandini F, Castello E, Mazzella L, Mancardi GL, Solaro C. Gabapentin but not vigabatrin is effective in the treatment of acquired nystagmus in multiple sclerosis: how valid is the GABAergic hypothesis? J Neurol Neurosurg Psychiatry. 2001;71(1):107–10.PubMedCrossRefGoogle Scholar
  63. 63.
    Starck M, Albrecht H, Pollmann W, Straube A, Dieterich M. Drug therapy for acquired pendular nystagmus in multiple sclerosis. J Neurol. 1997;244(1):9–16.PubMedCrossRefGoogle Scholar
  64. 64.
    Starck M, Albrecht H, Pollmann W, Dieterich M, Straube A. Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin. J Neurol. 2010;257(3):322–7. Epub 2009/09/17.PubMedCrossRefGoogle Scholar
  65. 65.
    •• Thurtell MJ, Joshi AC, Leone AC, Tomsak RL, Kosmorsky GS, Stahl JS, et al. Crossover trial of gabapentin and memantine as treatment for acquired nystagmus. Ann Neurol. 2010;67(5):676–80. Epub 2010/05/04. A randomized masked trial reiterating the benefits of gabapentin and memantine in APN. PubMedGoogle Scholar
  66. 66.
    Eroglu C, Allen NJ, Susman MW, O'Rourke NA, Park CY, Ozkan E, et al. Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell. 2009;139(2):380–92. Epub 2009/10/13.PubMedCrossRefGoogle Scholar
  67. 67.
    Cohen B, Helwig D, Raphan T. Baclofen and velocity storage: a model of the effects of the drug on the vestibulo-ocular reflex in the rhesus monkey. J Physiol. 1987;393:703–25.PubMedGoogle Scholar
  68. 68.
    Uemura T, Inoue H, Hirano T. The effects of baclofen on periodic alternating nystagmus and experimentally induced nystagmus. Adv Oto Rhino Laryngol. 1988;42:254–9.Google Scholar
  69. 69.
    Troost BT, Janton F, Weaver R. Periodic alternating oscillopsia: a symptom of alternating nystagmus abolished by baclofen. J Clin Neuro Ophthalmol. 1990;10(4):273–7.Google Scholar
  70. 70.
    Garbutt S, Thakore N, Rucker J, Han Y, Kumar A, Leigh RJ. Effects of visual fixation and convergence on periodic alternating nystagmus due to MS. Neuro-Ophthalmology. 2004;28(5–6):221–9.CrossRefGoogle Scholar
  71. 71.
    Comer RM, Dawson EL, Lee JP. Baclofen for patients with congenital periodic alternating nystagmus. Strabismus. 2006;14(4):205–9.PubMedCrossRefGoogle Scholar
  72. 72.
    Solomon D, Shepard N, Mishra A. Congenital periodic alternating nystagmus: response to baclofen. Ann N Y Acad Sci. 2002;956:611–5.PubMedCrossRefGoogle Scholar
  73. 73.
    Pradeep A, Thomas S, Roberts EO, Proudlock FA, Gottlob I. Reduction of congenital nystagmus in a patient after smoking cannabis. Strabismus. 2008;16(1):29–32.PubMedCrossRefGoogle Scholar
  74. 74.
    Sarvananthan N, Proudlock FA, Choudhuri I, Dua H, Gottlob I. Pharmacologic treatment of congenital nystagmus. Arch Ophthalmol. 2006;124(6):916–8.PubMedCrossRefGoogle Scholar
  75. 75.
    von Noorden G, Sprunger D. Large rectus muscle recessions for the treatment of congenital nystagmus. Acta Ophthalmol. 1991;109:221–4.CrossRefGoogle Scholar
  76. 76.
    Atilla H, Erkam N, Isikcelik Y. Surgical treatment in nystagmus.[see comment]. Eye. 1999;13(Pt 1):11–5.PubMedCrossRefGoogle Scholar
  77. 77.
    Graf M, Droutsas K, Kaufmann H. Surgery for nystagmus related head turn: Kestenbaum procedure and artificial divergence. Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2001;239(5):334–41. Epub 2001/08/03.Google Scholar
  78. 78.
    Sendler S, Shallo-Hoffmann J, Muhlendyck H. Artificial divergence surgery in congenital nystagmus. Fortschr Ophthalmol. 1990;87(1):85–9. Epub 1990/01/01. Die Artifizielle-Divergenz-Operation beim kongenitalen Nystagmus.PubMedGoogle Scholar
  79. 79.
    Wang ZI, Dell'Osso LF, Tomsak RL, Jacobs JB. Combining recessions (nystagmus and strabismus) with tenotomy improved visual function and decreased oscillopsia and diplopia in acquired downbeat nystagmus and in horizontal infantile nystagmus syndrome. J Aapos Am Assoc Pediatr Ophthalmol Strabismus. 2007;11(2):135–41.CrossRefGoogle Scholar
  80. 80.
    •• Kumar A, Shetty S, Vijayalakshmi P, Hertle RW. Improvement in visual acuity following surgery for correction of head posture in infantile nystagmus syndrome. J Pediatr Ophthalmol Strabismus. 2011:1–6. Epub 2011/01/26. A recent paper proposing that surgery for abnormal head posture in IN also improves visual acuity. Google Scholar
  81. 81.
    Hertle RW, Yang D, Adams K, Caterino R. Surgery for the treatment of vertical head posturing associated with infantile nystagmus syndrome: results in 24 patients. Clin Exp Ophthalmol. 2011;39(1):37–46. Epub 2010/07/29.Google Scholar
  82. 82.
    Hertle RW, Felius J, Yang D, Kaufman M. Eye muscle surgery for infantile nystagmus syndrome in the first 2 years of life. Clin Ophthalmol. 2009;3:615–24. Epub 2009/12/10.PubMedCrossRefGoogle Scholar
  83. 83.
    Hertle RW. Examination and refractive management of patients with nystagmus. Surv Ophthalmol. 2000;45(3):215–22. Epub 2000/11/30.PubMedCrossRefGoogle Scholar
  84. 84.
    Allen ED, Davies PD. Role of contact lenses in the management of congenital nystagmus. Br J Ophthalmol. 1983;67(12):834–6. Epub 1983/12/01.PubMedCrossRefGoogle Scholar
  85. 85.
    Golubovic S, Marjanovic S, Cvetkovic D, Manic S. The application of hard contact lenses in patients with congenital nystagmus. Fortschr Ophthalmol. 1989;86(5):535–9. Epub 1989/01/01.PubMedGoogle Scholar
  86. 86.
    Matsubayashi K, Fukushima M, Tabuchi A. Application of soft contact lenses for children with congenital nystagmus. Neuro-Ophthalmology. 1992;12(1):47–52.Google Scholar
  87. 87.
    Rutner D, Ciuffreda K. Soft contact lenses to improve motor and sensory function in congenital nystagmus. J Behav Optom. 2005;16(1):17–20.Google Scholar
  88. 88.
    Dell'Osso LF, Traccis S, Abel LA, Erzurum SI. Contact lenses and congenital nystagmus. Clin Vis Sci. 1988;3(3):229–32.Google Scholar
  89. 89.
    Taibbi G, Wang ZI, Dell'Osso LF. Infantile nystagmus syndrome: broadening the high-foveation-quality field with contact lenses. Clin Ophthalmol. 2008;2(3):585–9. Epub 2009/08/12.PubMedGoogle Scholar
  90. 90.
    Spielmann A. Nystagmus. Curr Opin Ophthalmol. 1994;5(5):20–4.PubMedCrossRefGoogle Scholar
  91. 91.
    Barton JJ, Cox TA, Digre KB. Acquired convergence-evoked pendular nystagmus in multiple sclerosis. J Neuro Ophthalmol. 1999;19(1):34–8.CrossRefGoogle Scholar
  92. 92.
    Repka MX, Savino PJ, Reinecke RD. Treatment of acquired nystagmus with botulinum neurotoxin A. Arch Ophthalmol. 1994;112(10):1320–4.PubMedCrossRefGoogle Scholar
  93. 93.
    Leigh RJ, Tomsak RL, Grant MP, Remler BF, Yaniglos SS, Lystad L, et al. Effectiveness of botulinum toxin administered to abolish acquired nystagmus. Ann Neurol. 1992;32(5):633–42.PubMedCrossRefGoogle Scholar
  94. 94.
    Tomsak RL, Remler BF, Averbuch-Heller L, Chandran M, Leigh RJ. Unsatisfactory treatment of acquired nystagmus with retrobulbar injection of botulinum toxin. Am J Ophthalmol. 1995;119(4):489–96.PubMedGoogle Scholar
  95. 95.
    Abadi RV, Carden D, Simpson J. A new treatment for congenital nystagmus. Br J Ophthalmol. 1980;64(1):2–6.PubMedCrossRefGoogle Scholar
  96. 96.
    Jain S, Proudlock F, Constantinescu CS, Gottlob I. Combined pharmacologic and surgical approach to acquired nystagmus due to multiple sclerosis. Am J Ophthalmol. 2002;134(5):780–2. Epub 2002/11/14.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Rebecca Jane McLean
    • 1
    Email author
  • Irene Gottlob
    • 1
  • Frank Antony Proudlock
    • 1
  1. 1.Robert Kilpatrick Clinical Sciences Building, Leicester Royal InfirmaryOphthalmology Group, University of Leicester, Faculty of Medicine & Biological SciencesLeicesterUK

Personalised recommendations